Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica
Background: Esophageal carcinoma has a dismal prognosis. Several authors have reported a very low survival in Chile. Aim: To report the survival of patients with esophageal carcinoma, subjected to esophageal resection. Material and methods: Analysis of 108 patients subjected to thoracic esophageal r...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2000
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000100009 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872000000100009 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720000001000092000-05-25Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácicaBraghetto M,taloCsendes J,AttilaCornejo O,AquilesAmat V,JoséCardemil H,GonzaloBurdiles P,PatricioKorn B,Owen Esophageal neoplasms Neoplasm staging Surgery, operative Background: Esophageal carcinoma has a dismal prognosis. Several authors have reported a very low survival in Chile. Aim: To report the survival of patients with esophageal carcinoma, subjected to esophageal resection. Material and methods: Analysis of 108 patients subjected to thoracic esophageal resection between 1985 and 1996. Patients were classified according to the location of the tumor and its staging. Results: Eleven patients died in the immediate postoperative period and 90 patients were followed. In 53 the exact cause of death was determined. Global five years survival was 29% and median survival was 18 months. Survival was 100% in stage I tumors. Adjuvant therapy resulted in a better survival of stage III tumors. Survival of stage IV tumors was worst than stage I to III tumors. There was no survival difference between squamous carcinoma or adenocarcinoma. Tumors located in the superior third of the esophagus had a worst prognosis. Causes of death were mediastinic metastases, local recidivism, pleural or pulmonary metastases and less frequently, brain, bronchial or bone metastases. Conclusions: The survival of these, patients with esophageal carcinoma did not differ from the figures reported abroad. (Rev Méd Chile 2000; 128: 64-74)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.128 n.1 20002000-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000100009es10.4067/S0034-98872000000100009 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Esophageal neoplasms Neoplasm staging Surgery, operative |
spellingShingle |
Esophageal neoplasms Neoplasm staging Surgery, operative Braghetto M,talo Csendes J,Attila Cornejo O,Aquiles Amat V,José Cardemil H,Gonzalo Burdiles P,Patricio Korn B,Owen Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica |
description |
Background: Esophageal carcinoma has a dismal prognosis. Several authors have reported a very low survival in Chile. Aim: To report the survival of patients with esophageal carcinoma, subjected to esophageal resection. Material and methods: Analysis of 108 patients subjected to thoracic esophageal resection between 1985 and 1996. Patients were classified according to the location of the tumor and its staging. Results: Eleven patients died in the immediate postoperative period and 90 patients were followed. In 53 the exact cause of death was determined. Global five years survival was 29% and median survival was 18 months. Survival was 100% in stage I tumors. Adjuvant therapy resulted in a better survival of stage III tumors. Survival of stage IV tumors was worst than stage I to III tumors. There was no survival difference between squamous carcinoma or adenocarcinoma. Tumors located in the superior third of the esophagus had a worst prognosis. Causes of death were mediastinic metastases, local recidivism, pleural or pulmonary metastases and less frequently, brain, bronchial or bone metastases. Conclusions: The survival of these, patients with esophageal carcinoma did not differ from the figures reported abroad. (Rev Méd Chile 2000; 128: 64-74) |
author |
Braghetto M,talo Csendes J,Attila Cornejo O,Aquiles Amat V,José Cardemil H,Gonzalo Burdiles P,Patricio Korn B,Owen |
author_facet |
Braghetto M,talo Csendes J,Attila Cornejo O,Aquiles Amat V,José Cardemil H,Gonzalo Burdiles P,Patricio Korn B,Owen |
author_sort |
Braghetto M,talo |
title |
Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica |
title_short |
Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica |
title_full |
Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica |
title_fullStr |
Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica |
title_full_unstemmed |
Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica |
title_sort |
sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica |
publisher |
Sociedad Médica de Santiago |
publishDate |
2000 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000100009 |
work_keys_str_mv |
AT braghettomtalo sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica AT csendesjattila sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica AT cornejooaquiles sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica AT amatvjose sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica AT cardemilhgonzalo sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica AT burdilesppatricio sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica AT kornbowen sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica |
_version_ |
1718435899895709696 |